Ayushman Bharat Fraud Crackdown: Govt Rejects ₹643 Crore Worth of Bogus Claims

The Indian government has taken stringent action against fraudulent health insurance claims under the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). As per Union Minister of State for Health, Prataprao Jadhav, authorities have rejected 3.56 lakh fraudulent claims worth ₹643 crore and de-empanelled 1,114 hospitals involved in irregularities. Additionally, 1,504 hospitals have been fined ₹122 crore, and 549 hospitals have been suspended for violating the scheme’s guidelines.

Ayushman Bharat: India’s Flagship Health Insurance Scheme

Launched as a healthcare safety net for economically disadvantaged families, Ayushman Bharat provides annual health coverage of ₹5 lakh per family for secondary and tertiary care hospitalisation. In October 2024, the scheme was expanded to include all senior citizens aged 70 and above, benefiting nearly 6 crore individuals from 4.5 crore families.

To ensure transparency and prevent misuse, the scheme follows a zero-tolerance policy towards fraud and irregularities, with multiple layers of monitoring and enforcement.

A Multi-Layered Anti-Fraud Mechanism

To safeguard the scheme from exploitation, the National Anti-Fraud Unit (NAFU) has been set up with a dedicated focus on fraud prevention, detection, and deterrence. This unit monitors transactions and claims to identify potential fraudulent activities.

Key Fraud Triggers in the System

To maintain integrity, the Transaction Management System (TMS) has been designed with built-in fraud detection mechanisms. Some of the common fraudulent practices flagged include:

• Upcoding of health benefit packages – Inflating costs by charging for a more expensive treatment than what was provided.
• OPD to IPD conversion – Falsely admitting patients for inpatient treatment when only outpatient services were required.
• Ghost billing – Raising claims for treatments never rendered.
• Duplicate images and documents – Using the same patient records for multiple claims.
• Forgery and impersonation – Submitting claims using falsified documents or counterfeit beneficiary details.

When such anomalies are detected, automatic flags are raised, leading to investigations and potential penalties.

Aadhaar-Based Verification to Prevent Duplication

To curb fraudulent claims, Aadhaar e-KYC authentication is mandatory for beneficiaries at the time of enrolment and again at the time of availing healthcare services. This prevents duplicate registrations and ensures that only genuine beneficiaries receive treatment under the scheme.

AI-Powered Surveillance and Random Audits

The government has integrated artificial intelligence (AI) and near real-time monitoring to track hospital claims. Additionally, random audits and surprise inspections are conducted to assess the authenticity of medical claims submitted by hospitals.

Grievance Redressal Mechanism for Beneficiaries

To empower beneficiaries and ensure accountability, a three-tier grievance redressal system has been established at the district, state, and national levels. Dedicated nodal officers and committees oversee complaint resolutions. Beneficiaries can raise grievances through:

• Centralised Grievance Redressal Management System (CGRMS)
• State and central call centres
• Emails and official letters

This system ensures that any unfair denial of claims or wrongful blacklisting of hospitals is appropriately addressed.

Conclusion

The Indian government’s strict enforcement measures and advanced fraud detection mechanisms aim to protect the Ayushman Bharat scheme from financial misuse. By leveraging technology, audits, and grievance redressal, authorities continue to uphold transparency and ensure that genuine beneficiaries receive the healthcare support they are entitled to.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.